Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis

被引:1
作者
Ferrari, Vittorio [1 ]
Terlizzi, Vito [2 ]
Stagi, Stefano [1 ]
机构
[1] Univ Florence, Anna Meyer Childrens Univ Hosp, Dept Hlth Sci, I-50100 Florence, Italy
[2] Meyer Childrens Hosp, Cyst Fibrosis Reg Reference Ctr, Dept Paediat Med, I-50139 Florence, Italy
关键词
cystic fibrosis; CFTR; growth failure; short stature; puberty delay; hypothyroidism; bone; hypogonadism; infertility; diabetes; children; adolescents; BONE-MINERAL DENSITY; THYROID-FUNCTION; GROWTH-HORMONE; INSULIN-SECRETION; GLUCOSE-TOLERANCE; BODY-COMPOSITION; CFTR; DEFICIENCY; WEIGHT; ADULTS;
D O I
10.3390/jcm11144041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis (CF) is a multisystem autosomal recessive disease caused by mutations that lead to deficient or dysfunctional CF transmembrane conductance regulator (CFTR) proteins. Patients typically present malnutrition resulting from the malabsorption of fundamental nutrients and recurring lung infections, with a progressive worsening of the respiratory function. For these reasons, the clinical management of CF requires a multidisciplinary team. From an endocrinological point of view, patients often present major complications, such as diabetes, bone disease, thyroid disorders, delayed growth and puberty, hypogonadism and infertility, which negatively affect their quality of life and, in some cases, significantly reduce life expectancy. These complications can arise as a direct result of CFTR dysfunction and/or as a consequence of a deterioration in the function of the organs affected. The objective of this review is to analyze all the possible endocrinological complications that can occur in patients with CF by evaluating the most recent papers in the literature.
引用
收藏
页数:18
相关论文
共 129 条
  • [1] Glucocorticoid-induced osteoporosis: 2019 concise clinical review
    Adami, G.
    Saag, K. G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1145 - 1156
  • [2] Cystic fibrosis and fertility
    Ahmad, Asima
    Ahmed, Aysha
    Patrizio, Pasquale
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (03) : 167 - 172
  • [3] ALLAN JL, 1974, AUST PAEDIATR J, V10, P136
  • [4] Growth suppression by glucocorticoid therapy
    Allen, DB
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (03) : 699 - &
  • [5] Consensus statement: Guide to bone health and disease in cystic fibrosis
    Aris, RM
    Merkel, PA
    Bachrach, LK
    Borowitz, DS
    Boyle, MP
    Elkin, SL
    Guise, TA
    Hardin, DS
    Haworth, CS
    Holick, MF
    Joseph, PM
    O'Brien, K
    Tullis, E
    Watts, NB
    White, TB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) : 1888 - 1896
  • [6] Altered calcium homeostasis in adults with cystic fibrosis
    Aris, RM
    Lester, GE
    Dingman, S
    Ontjes, DA
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 10 (02) : 102 - 108
  • [7] Carboxylated osteocalcin levels in cystic fibrosis
    Aris, RM
    Ontjes, DA
    Brown, SA
    Chalermskulrat, W
    Neuringer, I
    Lester, GE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (09) : 1129 - 1129
  • [8] Azizi F, 1974, Trans Assoc Am Physicians, V87, P111
  • [9] Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study
    Bellin, Melena D.
    Laguna, Theresa
    Leschyshyn, Janice
    Regelmann, Warren
    Dunitz, Jordan
    Billings, JoAnne
    Moran, Antoinette
    [J]. PEDIATRIC DIABETES, 2013, 14 (06) : 417 - 421
  • [10] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
    Bhasin, Shalender
    Brito, Juan P.
    Cunningham, Glenn R.
    Hayes, Frances J.
    Hodis, Howard N.
    Matsumoto, Alvin M.
    Snyder, Peter J.
    Swerdloff, Ronald S.
    Wu, Frederick C.
    Yialamas, Maria A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (05) : 1715 - 1744